Surgical Management for Suburethral Slings

March 6, 2024 updated by: Prof. Dr. Volker Viereck, Cantonal Hospital, Frauenfeld

Prospective, Non-Randomized, Observational Trial of the Surgical Management for Suburethral Slings in Women With Stress Urinary Incontinence

This is a prospective, non-randomized, observational, single center study in which subjects that have surgically-correctable Stress Urinary Incontinence undergo a suburethral sling operative procedure.

Study Overview

Status

Recruiting

Detailed Description

The study will collect preoperative urologic testing, medical history, and subject quality of life patient questionnaires. Intraoperative procedural data will be collected.

Postoperative complications, urologic, testing, and subject questionnaires will be collected at intervals. The anatomic position of the device will be characterize by introital ultrasound testing.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Thurgau
      • Frauenfeld, Thurgau, Switzerland, 8501
        • Recruiting
        • Blasenzentrum, Cantonal Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Volker VV Viereck, Physican
        • Sub-Investigator:
          • Oliver OR Rautenberg, Physican

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Subjects that have surgically-correctable Stress Urinary Incontinence and undergo a suburethral sling operative procedure.

Description

Inclusion Criteria:

  1. Patient has objective demonstrable signs of stress urinary incontinence (SUI), including patients with intrinsic sphincter deficiency (ISD). Objective testing includes: standing stress test, urodynamics evaluation, or pad test.
  2. Patient is age 18 or older.
  3. Patient agrees to participate in the study, including completion of all study-related procedures and evaluations, and documents this agreement by signing the IRB/EC-approved informed consent.
  4. Patient is able to fill in all questionnaires (on judgement of investigator)

Exclusion Criteria:

  1. Patient has an associated or suspected neurological disease.
  2. Patient has an active lesion or present injury to perineum or urethra.
  3. Patient has a urethral obstruction.
  4. Patient has significant pelvic organ prolapse (Grade III/IV) requiring surgical treatment.
  5. The subject has current urinary tract infection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Stress Urinary Incontinence
Females with stress urinary incontinence, who undergo a tension free surgical sling procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cure/improvement rate
Time Frame: 3 months
Patients are classified as cured if the postoperative cough test (see Outcome 4 below) is negative and the degree of subjective suffering (see Outcome 2 below) improves to over 90% (VAS score of 0 or 1). Criteria for improvement are involuntary loss of only a few drops of urine during straining and an improvement of the degree of suffering to over 75% (VAS score of 2 or 3). All other patients are classified as therapeutic failures (even if they show marked improvement of one of the parameters compared with their preoperative status).
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective symptom assessment by visual analogue scale
Time Frame: 3 and 6 months
Scale: 0-10 (0-no suffering, 10-severe suffering)
3 and 6 months
Post-Operative Pain Assessment
Time Frame: 1 day
Scale: 0-10 (0-no pain, 10-severe pain)
1 day
Standing Cough Stress Test
Time Frame: baseline, 3 and 6 months
3 categories: negative/severe, if flow of urine is observed. negative/mild, if the loss of only a few drops is observed. positive, if no urine loss occurs.
baseline, 3 and 6 months
King Health Questionnaire
Time Frame: pre-operation, 3 and 6 months
pre-operation, 3 and 6 months
International Consultation on Incontinence Questionnaire
Time Frame: pre-operation, 3 and 6 months
pre-operation, 3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Volker Viereck, Physican, Cantonal Hospital, Frauenfeld

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

May 19, 2016

First Submitted That Met QC Criteria

May 26, 2016

First Posted (Estimated)

May 27, 2016

Study Record Updates

Last Update Posted (Actual)

March 7, 2024

Last Update Submitted That Met QC Criteria

March 6, 2024

Last Verified

March 1, 2024

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Urinary Incontinence

3
Subscribe